About the OMERACT Scleroderma Vascular Disease Working Group
Systemic sclerosis (also called scleroderma) is a multi-system autoimmune disease with several organ- and life-threatening manifestations. Progress in developing effective treatments for scleroderma has, in part, been hampered by a lack of reliable, feasible, and valid outcome measures. The OMERACT Scleroderma Vascular Disease Working Group has been working to draft a core set of domains relevant to the study of two related manifestations of disease: Raynaud’s phenomenon and digital ulcers. This SIG, the first for this group, will outline the significant progress made to date and seek input from the OMERACT community about next steps in the process.

Ariane Herrick
Co-Chair

Peter Merkel
Co-Chair

John Pauling
Co-Chair

Susanna Proudman
Co-Chair
Introductory video to Systemic Sclerosis with a focus on Raynaud's phenomenon and digital ulcers
Working Group Members:
John Pauling
Peter Merkel
Susanna Proudman
Edith Brown
Virginia Hickey
Michael Hughes
Nancy Maltez
Bev Shea
Heiyoung Park
Peter Tugwell
Ashima Makol